Log in

Relevant bibliographies by topics / Esophagus Squamous cell carcinoma Gene expression / Journal articles

To see the other types of publications on this topic, follow the link: Esophagus Squamous cell carcinoma Gene expression.

Journal articles on the topic 'Esophagus Squamous cell carcinoma Gene expression'

Author: Grafiati

Published: 4 June 2021

Last updated: 15 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Esophagus Squamous cell carcinoma Gene expression.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

van Baal, Jantine W. P. M., Francesco Milana, Agnieszka M. Rygiel, et al. "A comparative Analysis by SAGE of Gene Expression Profiles of Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma." Analytical Cellular Pathology 30, no. 1 (2008): 63–75. http://dx.doi.org/10.1155/2008/328529.

Full text

Abstract:

Esophageal adenocarcinoma (EA) and esophageal squamous cell carcinoma (ESCC) are the two main types of esophageal cancer. Despite extensive research the exact molecular basis of these cancers is unclear. Therefore we evaluated the transcriptome of EA in comparison to non-dysplastic Barrett’s esophagus (BE), the metaplastic epithelium that predisposes for EA, and compared the transcriptome of ESCC to normal esophageal squamous epithelium. For obtaining the transcriptomes tissue biopsies were used and serial analysis of gene expression (SAGE) was applied. Validation of results by RT-PCR and immu

APA, Harvard, Vancouver, ISO, and other styles

2

Lu, Jiayun, Zhihua Liu, Momiao Xiong, et al. "Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus." International Journal of Cancer 91, no. 3 (2001): 288–94. http://dx.doi.org/10.1002/1097-0215(200002)9999:9999<::aid-ijc1063>3.0.co;2-s.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Terayama, Masayoshi, Teruki Hagiwara, Kazuhiko Yamada, et al. "PS02.048: DECREASED EXPRESSION OF PRSS27 IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA." Diseases of the Esophagus 31, Supplement_1 (2018): 134. http://dx.doi.org/10.1093/dote/doy089.ps02.048.

Full text

Abstract:

Abstract Background Alcohol drinking and smoking are substantial risk factors of esophageal squamous cell carcinoma (ESCC) and are supposed to induce genetic mutations and epigenetic disorders, including aberrant DNA methylation. Previously, we have conducted transcriptome and methylome analyses of a paired specimen of ESCC and adjacent non-cancerous tissues and found that both gene expression and promotor methylation of PRSS27 were perturbed in ESCC. PRSS27 was a trypsin-like serine protease (also known as marapsin) and expressed in normal esophagus; however, little is known about the signifi

APA, Harvard, Vancouver, ISO, and other styles

4

Kajiwara, T., T. Nishina, I. Hyodo, et al. "Impact of gene expression of orotate phosphoribosyl transferase for complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus." Journal of Clinical Oncology 25, no. 18_suppl (2007): 4566. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.4566.

Full text

Abstract:

4566 Background: Chemoradiotherapy (CRT) is a potential alternative to surgery in patients with squamous cell carcinoma of the esophagus. Complete response (CR) to CRT is essential for a good prognosis and there is a need for a predictive method of CR in CRT. Methods: The pretreatment formalin-fixed, paraffin-embedded endoscopic tumor biopsy material was obtained from 41 patients treated with a definitive concurrent CRT (5-FU/CDDP and 60 Gy) for esophageal cancer (cStage II or III). cDNA was derived from tumor cells of biopsy specimens by the laser capture microdissection and analyzed to deter

APA, Harvard, Vancouver, ISO, and other styles

5

Chen, Shirui, Kai Zhou, Liguang Yang, Guohui Ding, and Hong Li. "Racial Differences in Esophageal Squamous Cell Carcinoma: Incidence and Molecular Features." BioMed Research International 2017 (2017): 1–9. http://dx.doi.org/10.1155/2017/1204082.

Full text

Abstract:

The incidence and histological type of esophageal cancer are highly variable depending on geographic location and race/ethnicity. Here we want to determine if racial difference exists in the molecular features of esophageal cancer. We firstly confirmed that the incidence rate of esophagus adenocarcinoma (EA) was higher in Whites than in Asians and Blacks, while the incidence of esophageal squamous cell carcinoma (ESCC) was highest in Asians. Then we compared the genome-wide somatic mutations, methylation, and gene expression to identify differential genes by race. The mutation frequencies of s

APA, Harvard, Vancouver, ISO, and other styles

6

Greenawalt, Danielle M., Cuong Duong, Gordon K. Smyth, et al. "Gene expression profiling of esophageal cancer: Comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma." International Journal of Cancer 120, no. 9 (2007): 1914–21. http://dx.doi.org/10.1002/ijc.22501.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Tada, Takeshi, Reiko Honma, Jun-Ichi Imai, et al. "A novel gene expression scoring system for accurate diagnosis of basaloid squamous cell carcinoma of the esophagus." International Journal of Oncology 51, no. 3 (2017): 877–86. http://dx.doi.org/10.3892/ijo.2017.4075.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Zhou, Yalu, Joel L. Schwartz, Saurabh Sinha, Ardaman Shergill, and Guy Adami. "A large subtype of squamous cell carcinoma enriched for TrkB-T1 mRNA." Journal of Clinical Oncology 37, no. 15_suppl (2019): e14751-e14751. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14751.

Full text

Abstract:

e14751 Background: A large subtype of squamous cell carcinoma enriched for TrkB-T1 mRNA. Background The NTRK2 genetic locus encodes neurotrophin membrane receptors that play an important role in normal neural tissue plasticity, growth, and survival. One NTRK2-encoded protein is TrkB-FL, which can regulate multiple pathways relevant to cancer. A second NTRK2 gene mRNA isoform encodes TrkB-T1, a receptor that has a different cytoplasmic domain and is encoded in a mRNA with a unique 3’ terminal exon. Methods: Tumors from The Cancer Genome Atlas (TCGA) and other studies were classified according t

APA, Harvard, Vancouver, ISO, and other styles

9

Hibino, Soki, Mitsuro Kanda, Hisaharu Oya, et al. "Reduced expression of DENND2D through promoter hypermethylation as an adverse prognostic factor in squamous cell carcinoma of the esophagus." Journal of Clinical Oncology 32, no. 3_suppl (2014): 58. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.58.

Full text

Abstract:

58 Background: Esophageal cancer ranks sixth in cancer mortality worldwide and patients with ESCC have a poor prognosis with a 5-year survival rate of less than 10%. Elucidation of the mechanisms of carcinogenesis and tumor progression in esophageal cancer is urgently needed to develop targets for therapy and prognostic biomarkers. In the present study, the expression and regulatory mechanism of the Differentially Expressed in Normal and Neoplastic cells Domain containing 2D (DENND2D), which is a regulator of Rab GTPases, were investigated to explore its potential as a tumor suppressor gene fo

APA, Harvard, Vancouver, ISO, and other styles

10

Ojima, Toshiyasu, Mikihito Nakamori, Masaki Nakamura, et al. "Expression of ERCC1, TUBB3, BRCA1, and TS as predictive markers of neoadjuvant chemotherapy for squamous cell carcinoma of the esophagus." Journal of Clinical Oncology 34, no. 4_suppl (2016): 47. http://dx.doi.org/10.1200/jco.2016.34.4_suppl.47.

Full text

Abstract:

47 Background: No predictive biomarker of the response to neoadjuvant chemotherapy with docetaxel and cisplatin plus 5-fluorouracil (NAC-DCF) is available for patients with squamous cell carcinoma of the esophagus (SCCE) in a clinical setting. The aim of this study was to identify the biomarkers associated with chemotherapeutic efficacy and long-term survival for patients with advanced SCCE who had received NAC-DCF followed by surgery. Methods: This study included 45 patients with advanced SCCE who received NAC-DCF between January 2008 and December 2012. The NAC-DCF was conducted as a phase II

APA, Harvard, Vancouver, ISO, and other styles

11

Kajiwara, Takeshi, Tomohiro Nishina, Ichinosuke Hyodo, et al. "High Orotate Phosphoribosyltransferase Gene Expression Predicts Complete Response to Chemoradiotherapy in Patients with Squamous Cell Carcinoma of the Esophagus." Oncology 76, no. 5 (2009): 342–49. http://dx.doi.org/10.1159/000209964.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Qu, Ning, Dongzhe Huang, Qinghua Xu, et al. "Gene expression profiling of cells of origin of squamous cell carcinomas in head-and-neck, esophagus, and lung." Acta Biochimica et Biophysica Sinica 52, no. 2 (2020): 211–14. http://dx.doi.org/10.1093/abbs/gmz153.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Kan, Takatsugu, Seiji Yamasaki, Kan Kondo, et al. "A New Specific Gene Expression in Squamous Cell Carcinoma of the Esophagus Detected Using Representational Difference Analysis and cDNA Microarray." Oncology 70, no. 1 (2006): 25–33. http://dx.doi.org/10.1159/000091183.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Qu, Ning, Dongzhe Huang, Qinghua Xu, et al. "Corrigendum to: Gene expression profiling of cells of origin of squamous cell carcinomas in head-and-neck, esophagus, and lung." Acta Biochimica et Biophysica Sinica 52, no. 9 (2020): 1053. http://dx.doi.org/10.1093/abbs/gmaa079.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Hayashi, Kazuhiko, Ralf Metzger, Dennis Salonga та ін. "High frequency of simultaneous loss of p16 and p16β gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach". Oncogene 15, № 12 (1997): 1481–88. http://dx.doi.org/10.1038/sj.onc.1201295.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Doi, Toshihiko, Sarina A. Piha-Paul, Shadia I. Jalal, et al. "Safety and Antitumor Activity of the Anti–Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma." Journal of Clinical Oncology 36, no. 1 (2018): 61–67. http://dx.doi.org/10.1200/jco.2017.74.9846.

Full text

Abstract:

PurposeThe anti–programmed death-1 antibody pembrolizumab was evaluated in KEYNOTE-028, a multicohort, phase IB study of patients with programmed death ligand-1 (PD-L1)–positive advanced solid tumors. Results from the esophageal carcinoma cohort are reported herein.Patients and MethodsEligible patients with squamous cell carcinoma or adenocarcinoma of the esophagus or gastroesophageal junction in whom standard therapy failed and who had PD-L1–positive tumors received pembrolizumab 10 mg/kg every 2 weeks for up to 2 years or until confirmed disease progression or intolerable toxicity. Response

APA, Harvard, Vancouver, ISO, and other styles

17

Shah, Manish A., Jaafar Bennouna, Lin Shen, et al. "Pembrolizumab (MK-3475) for previously treated metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: Phase II KEYNOTE-180 study." Journal of Clinical Oncology 34, no. 4_suppl (2016): TPS189. http://dx.doi.org/10.1200/jco.2016.34.4_suppl.tps189.

Full text

Abstract:

TPS189 Background: PD-L1 is frequently overexpressed in esophageal cancer. Pembrolizumab is a humanized monoclonal antibody that targets the PD-1 receptor and blocks interaction with PD-L1 and PD-L2. In the multicohort, phase Ib KEYNOTE-028 trial, pembrolizumab showed manageable toxicity, a 30.4% ORR, and median duration of response of 40 wk in 23 patients (pts) with PD-L1+ advanced esophageal cancer. The single-arm, multicenter phase II KEYNOTE-180 trial is designed to further evaluate pembrolizumab as a monotherapy in pts with previously treated advanced/metastatic esophageal cancer. Methods

APA, Harvard, Vancouver, ISO, and other styles

18

Kazemi-Noureini, Sakineh. "Differential gene expression between squamous cell carcinoma of esophageus and its normal epithelium; altered pattern of mal, akr1c2, and rab11a expression." World Journal of Gastroenterology 10, no. 12 (2004): 1716. http://dx.doi.org/10.3748/wjg.v10.i12.1716.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Fong, Louise Y., Cristian Taccioli, Alexey Palamarchuk, et al. "Abrogation of esophageal carcinoma development in miR-31 knockout rats." Proceedings of the National Academy of Sciences 117, no. 11 (2020): 6075–85. http://dx.doi.org/10.1073/pnas.1920333117.

Full text

Abstract:

MicroRNA-31 (miR-31) is overexpressed in esophageal squamous cell carcinoma (ESCC), a deadly disease associated with dietary Zn deficiency and inflammation. In a Zn deficiency-promoted rat ESCC model with miR-31 up-regulation, cancer-associated inflammation, and a high ESCC burden followingN-nitrosomethylbenzylamine (NMBA) exposure, systemic antimiR-31 delivery reduced ESCC incidence from 85 to 45% (P= 0.038) and miR-31 gene knockout abrogated development of ESCC (P= 1 × 10−6). Transcriptomics, genome sequencing, and metabolomics analyses in these Zn-deficient rats revealed the molecular basis

APA, Harvard, Vancouver, ISO, and other styles

20

Bosch, F. X., R. E. Leube, T. Achtstätter, R. Moll, and W. W. Franke. "Expression of simple epithelial type cytokeratins in stratified epithelia as detected by immunolocalization and hybridization in situ." Journal of Cell Biology 106, no. 5 (1988): 1635–48. http://dx.doi.org/10.1083/jcb.106.5.1635.

Full text

Abstract:

Multi-layered ("stratified") epithelia differ from one-layered ("simple") polar epithelia by various architectural and functional properties as well as by their cytoskeletal complements, notably a set of cytokeratins characteristic of stratified tissue. The simple epithelial cytokeratins 8 and 18 have so far not been detected in any stratified epithelium. Using specific monoclonal antibodies we have noted, in several but not all samples of stratified epithelia, including esophagus, tongue, exocervix, and vagina, positive immunocytochemical reactions for cytokeratins 8, 18, and 19 which in some

APA, Harvard, Vancouver, ISO, and other styles

21

Griguolo, Gaia, Fara Brasó-Maristany, Blanca González-Farré, et al. "ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer." Cancers 12, no. 7 (2020): 1902. http://dx.doi.org/10.3390/cancers12071902.

Full text

Abstract:

Trastuzumab emtansine (T-DM1) is approved for the treatment of human epidermal growth factor receptor 2 (HER2)-positive (HER2+) metastatic breast cancer (BC) and for residual disease after neoadjuvant therapy; however, not all patients benefit. Here, we hypothesized that the heterogeneity in the response seen in patients is partly explained by the levels of human epidermal growth factor receptor 2 gene (ERBB2) mRNA. We analyzed ERBB2 expression using a clinically applicable assay in formalin-fixed paraffin-embedded (FFPE) tumors (primary or metastatic) from a retrospective series of 77 patient

APA, Harvard, Vancouver, ISO, and other styles

22

Lurje, G., J. M. Leers, A. Pohl, et al. "Polymorphisms in epidermal growth factor (EGF) and proteinase activated receptor 1 (PAR-1) associated with tumor recurrence in localized adenocarcinoma (EA) of the esophagus treated with surgery alone." Journal of Clinical Oncology 27, no. 15_suppl (2009): 4564. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.4564.

Full text

Abstract:

4564 Background: Tumor angiogenesis is a well-recognized aspect of human cancer biology and is mediated at least in part by EGF and PAR-1, which in turn may impact the process of tumor growth and progression. Systemic tumor recurrence after curative resection continues to be a significant problem in the management of patients with localized EA. Further, it is being increasingly recognized that esophageal squamous cell carcinoma and EA are separate and distinct disease groups and need to be considered individually. We therefore designed a large retrospective study of EA patients to identify nov

APA, Harvard, Vancouver, ISO, and other styles

23

Liu, J.-F., G. Jamieson, T.-C. Wu, S.-W. Zhang, Q.-Z. Wang, and P. Drew. "Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus." Diseases of the Esophagus 19, no. 5 (2006): 350–54. http://dx.doi.org/10.1111/j.1442-2050.2006.00594.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Yu, Hong-Ping, Shun-Qing Xu, Li Liu, et al. "Cyclooxygenase-2 expression in squamous dysplasia and squamous cell carcinoma of the esophagus." Cancer Letters 198, no. 2 (2003): 193–201. http://dx.doi.org/10.1016/s0304-3835(03)00340-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Natsugoe, Shoji, Takashi Aikou, Mario Shimada, et al. "Expression of desmoglein I in squamous cell carcinoma of the esophagus." Journal of Surgical Oncology 57, no. 2 (1994): 105–10. http://dx.doi.org/10.1002/jso.2930570207.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Plaça, Jessica Rodrigues, Rafaela de Barros e. Lima Bueno, Daniel Guariz Pinheiro, et al. "Gene expression analysis of laryngeal squamous cell carcinoma." Genomics Data 5 (September 2015): 9–12. http://dx.doi.org/10.1016/j.gdata.2015.04.024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Mahale, Alka, Hind Alkatan, Saeed Alwadani, et al. "Altered gene expression in conjunctival squamous cell carcinoma." Modern Pathology 29, no. 5 (2016): 452–60. http://dx.doi.org/10.1038/modpathol.2016.41.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Sadri, Donia, Fatemeh Shahsavari, Sareh Farhadi, and Marzieh Sedehi. "Evaluation of Microvascularity by CD34 Expression in Esophagus and Oral Squamous Cell Carcinoma." Journal of Contemporary Dental Practice 16, no. 6 (2015): 458–62. http://dx.doi.org/10.5005/jp-journals-10024-1706.

Full text

Abstract:

ABSTRACT Aim The present study was scheduled to evaluate microvascularity by CD34 expression in esophagus and oral squamous cell carcinoma. Materials and methods This study was scheduled using 40 paraffin blocked samples including 20 of oral SCC and 20 of esophagus ones and Immunohistochemical staining was conducted using CD34 monoclonal antibody. Exact fisher test was used to evaluate frequency of expression between two studied groups. Results There was significant correlation between age and tumor size with CD34 expression in oral SCC samples (p < 0.05) and no significant correlation betw

APA, Harvard, Vancouver, ISO, and other styles

29

Hagen, Jeffrey. "VEGF-C Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus." World Journal of Surgery 31, no. 9 (2007): 1773–74. http://dx.doi.org/10.1007/s00268-007-9134-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Sarbia, Mario, Franz Borchard, Helmut E. Gabbert, Rainer Porschen, Olaf Horstmann, and Reinhart Willers. "P53 protein expression and prognosis in squamous cell carcinoma of the esophagus." Cancer 74, no. 8 (1994): 2218–23. http://dx.doi.org/10.1002/1097-0142(19941015)74:8<2218::aid-cncr2820740803>3.0.co;2-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Roye, G. Dean, Russell B. Myers, David Brown, Robert Poczatek, Samuel W. Beenken, and William E. Grizzle. "CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus." International Journal of Cancer 69, no. 4 (1996): 254–58. http://dx.doi.org/10.1002/(sici)1097-0215(19960822)69:4<254::aid-ijc2>3.0.co;2-w.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Möbius, Christian, José Freire, Ingrid Becker, et al. "VEGF-C Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus." World Journal of Surgery 31, no. 9 (2007): 1768–72. http://dx.doi.org/10.1007/s00268-006-0373-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Chen, Jing, Hongtao Liu, Pan Gao, et al. "Preliminary evaluation for Bit1 as a potential biomarker for squamous cell carcinoma and adenocarcinoma of esophagus." Tumor Biology 39, no. 5 (2017): 101042831770826. http://dx.doi.org/10.1177/1010428317708267.

Full text

Abstract:

Mounting evidence has demonstrated that Bit1 has been investigated as an etiological factor for certain cancers, including esophageal squamous cell carcinoma reported in our previous study, but data regarding possible roles of Bit1 in esophageal squamous cell carcinoma and esophageal adenocarcinoma remain to be elucidated. The purpose of this study was to examine whether Bit1 can be a novel diagnostic marker for the patients with esophageal squamous cell carcinoma and esophageal adenocarcinoma. The results revealed that Bit1 level in esophageal squamous cell carcinoma was significantly higher

APA, Harvard, Vancouver, ISO, and other styles

34

Liu, C. J., S. C. Lin, and K. W. Chang. "MicroRNA 145 gene expression in oral squamous cell carcinoma." International Journal of Oral and Maxillofacial Surgery 38, no. 5 (2009): 531–32. http://dx.doi.org/10.1016/j.ijom.2009.03.476.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Gupta, Parul, SaniaZ Rizvi, Nirupma Lal, Vishal Gupta, AnandN Srivastav, and Osman Musa. "Expression of CD44 and CD133 stem cell markers in squamous cell carcinoma of esophagus." Indian Journal of Pathology and Microbiology 64, no. 3 (2021): 472. http://dx.doi.org/10.4103/ijpm.ijpm_682_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

ISOBE, Tomohide, Gou YAMAMOTO, Tarou IRIE, Tetuhiko TACHIKAWA, and Kenji MISHIMA. "Gene Expression of Cancer Stem Cell in Oral Squamous Cell Carcinoma." Dental Medicine Research 32, no. 2 (2012): 81–89. http://dx.doi.org/10.7881/dentalmedres.32.81.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Jun, Zhang, Deng Denghao, Luo Jinyan та Wang Kangmin. "Immunohistochemical analysis of TGF β1 gene protein in squamous cell carcinoma of esophagus". Gastroenterology 114 (квітень 1998): A617. http://dx.doi.org/10.1016/s0016-5085(98)82519-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Nozoe, Tadahiro, Daisuke Korenaga, Shuhei Itoh, Motonori Futatsugi, and Yoshihiko Maehara. "Clinicopathological significance of pRb2/p130 expression in squamous cell carcinoma of the esophagus." Journal of Cancer Research and Clinical Oncology 128, no. 12 (2002): 691–96. http://dx.doi.org/10.1007/s00432-002-0395-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Chen, Gaoping, and Max M. Burger. "p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus." International Journal of Cancer 84, no. 2 (1999): 95–100. http://dx.doi.org/10.1002/(sici)1097-0215(19990420)84:2<95::aid-ijc1>3.0.co;2-n.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Zhao, Xiaojuan, Qingfeng Huang, Marjory Koller, et al. "Identification and Validation of Esophageal Squamous Cell Carcinoma Targets for Fluorescence Molecular Endoscopy." International Journal of Molecular Sciences 22, no. 17 (2021): 9270. http://dx.doi.org/10.3390/ijms22179270.

Full text

Abstract:

Dysplasia and intramucosal esophageal squamous cell carcinoma (ESCC) frequently go unnoticed with white-light endoscopy and, therefore, progress to invasive tumors. If suitable targets are available, fluorescence molecular endoscopy might be promising to improve early detection. Microarray expression data of patient-derived normal esophagus (n = 120) and ESCC samples (n = 118) were analyzed by functional genomic mRNA (FGmRNA) profiling to predict target upregulation on protein levels. The predicted top 60 upregulated genes were prioritized based on literature and immunohistochemistry (IHC) val

APA, Harvard, Vancouver, ISO, and other styles

41

Sharma, Rinu, Sharmishtha Samantaray, Nootan Kumar Shukla, and Ranju Ralhan. "Transcriptional gene expression profile of human esophageal squamous cell carcinoma." Genomics 81, no. 5 (2003): 481–88. http://dx.doi.org/10.1016/s0888-7543(03)00023-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Braakhuis, Boudewijn JM, Ruud H. Brakenhoff, and C. René Leemans. "Gene expression profiling in head and neck squamous cell carcinoma." Current Opinion in Otolaryngology & Head and Neck Surgery 18, no. 2 (2010): 67–71. http://dx.doi.org/10.1097/moo.0b013e32833693ce.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Zhu, Chang-Qi, Dan Strumpf, Chun-Yan Li, et al. "Prognostic Gene Expression Signature for Squamous Cell Carcinoma of Lung." Clinical Cancer Research 16, no. 20 (2010): 5038–47. http://dx.doi.org/10.1158/1078-0432.ccr-10-0612.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Tsukifuji, R., Y. Sakai, A. Hatamochi, and H. Shinkai. "047 Gene expression of matrix metalloproteinases in squamous cell carcinoma." Journal of Dermatological Science 12, no. 2 (1996): 189. http://dx.doi.org/10.1016/0923-1811(96)89445-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Liu, Xinyi, Ping Liu, Rebecca D. Chernock, et al. "A prognostic gene expression signature for oropharyngeal squamous cell carcinoma." EBioMedicine 61 (November 2020): 102805. http://dx.doi.org/10.1016/j.ebiom.2020.102805.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Kumar, Narender, Akhil Kapoor, Ashok Kalwar, et al. "Allele Frequency of ABO Blood Group Antigen and the Risk of Esophageal Cancer." BioMed Research International 2014 (2014): 1–6. http://dx.doi.org/10.1155/2014/286810.

Full text

Abstract:

Background. ABO blood group and risk of squamous cell carcinoma of esophagus have been reported by many studies, but there is no discipline that had provided association with the genotype and gene frequency by population statics.Methods. We conducted a case-control study on 480 patients with squamous cell carcinoma of the esophagus and 480 noncancer patients. ABO blood group was determined by presence of antigen with the help of monoclonal antibody. Chi-square test and odds ratio (OR) with 95% confidence intervals (CIs) were calculated by statistical methods, and gene frequencies were calculat

APA, Harvard, Vancouver, ISO, and other styles

47

Koide, Naohiko, Shoichiro Koike, Wataru Adachi, Jun Amano, Nobuteru Usuda, and Tetsuji Nagata. "Immunohistochemical expression of bcl-2 protein in squamous cell carcinoma and basaloid carcinoma of the esophagus." Surgery Today 27, no. 8 (1997): 685–91. http://dx.doi.org/10.1007/bf02384977.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Sakamoto, Naoya, Naohide Oue, Tsuyoshi Noguchi, et al. "Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma." Cancer Science 101, no. 4 (2009): 1038–44. http://dx.doi.org/10.1111/j.1349-7006.2009.01477.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Singhal, Sunil, Sunil Singhal, Anil Vachani, et al. "Gene expression profiling to distinguish head and neck squamous cell carcinoma metastases from primary lung squamous cell carcinoma." Journal of the American College of Surgeons 199, no. 3 (2004): 66–67. http://dx.doi.org/10.1016/j.jamcollsurg.2004.05.143.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Li, X., K. Sakamoto, Y. Takahashi, and T. Nakashima. "Overexpression of Cap43 gene in supraglottic laryngeal squamous cell carcinoma." Journal of Laryngology & Otology 123, S31 (2009): 11–17. http://dx.doi.org/10.1017/s0022215109005027.

Full text

Abstract:

AbstractObjective:This study aimed to determine the expression of the Cap43 gene in supraglottic laryngeal squamous cell carcinoma, and to evaluate any correlation between Cap43 gene expression and tumour-associated macrophage infiltration.Methods:Four human head and neck squamous cell carcinoma cell lines were cultured (Hep2, KB, Ca9-22 and HSC-3) and expression of the Cap43 gene was analysed by Western blotting. In addition, paraffin-embedded samples of supraglottic laryngeal squamous cell carcinoma and normal supraglottic laryngeal mucosa from 84 patients were analysed immunohistochemically

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!